Going Concern (Details Narrative) - USD ($)	3 Months Ended	119 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.		$ 41,645,688
Net Losses		33,429,962
Equity in Net Losses of Entest Biomedical, Inc.		$ 663,649
Proceeds from issuance of equity securities	$ 560,000